Allurion Technologies (ALUR) Cash & Equivalents (2022 - 2026)
Allurion Technologies (ALUR) posted Cash & Equivalents of $5.1 million for Q1 2026, down 6.58% on a QoQ basis from $5.4 million in Q4 2025, and down 75.23% year-over-year from $20.4 million in Q1 2025.
Allurion Technologies (ALUR) Cash & Equivalents (2022 - 2026) Analysis & Trends
Allurion Technologies' Cash & Equivalents history runs 5 years deep, the most recent figure standing at $5.1 million for Q1 2026.
- Quarterly Cash & Equivalents fell 75.23% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (down 75.23% YoY) and the FY2025 annual result came in at $5.4 million, down 64.81% from the prior year.
- Cash & Equivalents was $5.1 million for Q1 2026 at Allurion Technologies, down from $5.4 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $79.9 million in Q3 2023 and bottomed at $4.7 million in Q2 2023.
- A 5-year average of $21.0 million and a median of $15.4 million in 2024 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2023 — Cash & Equivalents soared 394.95% — and 2025, when it slumped 78.59%.
- Allurion Technologies' Cash & Equivalents stood at $7.7 million in 2022, then surged by 394.95% to $38.0 million in 2023, then slumped by 59.57% to $15.4 million in 2024, then tumbled by 64.81% to $5.4 million in 2025, then declined by 6.58% to $5.1 million in 2026.
- Business Quant data shows ALUR's Cash & Equivalents at $5.1 million in Q1 2026, $5.4 million in Q4 2025, and $6.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | 5.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.06 Mn |
| Dec 31, 2025 | 5.41 Mn |
| Sep 30, 2025 | 6.14 Mn |
| Jun 30, 2025 | 12.72 Mn |
| Mar 31, 2025 | 20.41 Mn |
| Dec 31, 2024 | 15.38 Mn |
| Sep 30, 2024 | 28.65 Mn |
| Jun 30, 2024 | 19.26 Mn |
| Mar 31, 2024 | 29.68 Mn |
| Dec 31, 2023 | 38.04 Mn |
| Sep 30, 2023 | 79.87 Mn |
| Jun 30, 2023 | 4.74 Mn |
| Dec 31, 2022 | 7.69 Mn |